发明名称 INHIBITOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME
摘要 PROBLEM TO BE SOLVED: To obtain a compound which can effectively inhibit the activity of interleukin-1βconverting enzyme (ICE) in vivo in order to be used as a medicinal agent for preventing or treating interleukin-1 mediated acute and chronic diseases, apoptosis-mediated diseases, inflammatory diseases, autoimmune diseases, bone destructive diseases, proliferative diseases, infectious diseases, degenerative and necrotic diseases. SOLUTION: This compound is represented by formulaαand formula (a) or (b) (wherein (n) is 0,1 or 2; R<SB>11</SB>is formula (a) or (b); m is 1 or 2; R<SB>12</SB>and R<SB>13</SB>are each independently selected from R<SB>7</SB>, C(O)-R<SB>7</SB>and C(O)-N(H)-R7, or they form in common a 4- to 8-membered saturated cyclic group). COPYRIGHT: (C)2004,JPO
申请公布号 JP2004143182(A) 申请公布日期 2004.05.20
申请号 JP20030408331 申请日期 2003.12.05
申请人 VERTEX PHARMACEUT INC 发明人 BEMIS GUY W;DUFFY JOHN P;FRIDMAN WOLF HERMAN;GOLEC JULIAN M C;LIVINGSTON DAVID J;MULLICAN MICHAEL D;MURCKO MARK A;ZELLE ROBERT E
分类号 A61K38/00;A61K38/55;A61P1/00;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P5/14;A61P7/00;A61P7/06;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P17/14;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/16;A61P25/28;A61P29/00;A61P31/00;A61P35/00;A61P35/02;A61P37/02;A61P43/00;C07K5/00;C07K5/02;C07K5/08;C07K5/083;(IPC1-7):C07K5/083 主分类号 A61K38/00
代理机构 代理人
主权项
地址